Verified Nov 2026
Other
·
Burlington, Massachusetts
·
Since 2014
scPharmaceuticals is a biopharmaceutical company headquartered in Burlington, Massachusetts, founded in 2014 and employing between 100 and 200 people. It develops subcutaneous delivery systems for cardiorenal care, serving patients with heart failure, chronic kidney disease, and fluid overload. Its lead product, FUROSCIX, is a subcutaneous diuretic delivered through a wearable on-body infusor that provides IV-equivalent diuresis at home. The company became part of MannKind Corporation after MannKind completed its acquisition of scPharmaceuticals in October 2025.
scPharmaceuticals at a glance
Revenue
36.3M
Employees
100-200
Founded
2014
Headquarters
Burlington, Massachusetts
Ownership
Publicly traded (NASDAQ: SCPH)
Industries
Automotive
Electric Vehicles
Medical
Overview
scPharmaceuticals is a biopharmaceutical company headquartered in Burlington, Massachusetts, founded in 2014 and employing between 100 and 200 people. It develops subcutaneous delivery systems for cardiorenal care, serving patients with heart failure, chronic kidney disease, and fluid overload. Its lead product, FUROSCIX, is a subcutaneous diuretic delivered through a wearable on-body infusor that provides IV-equivalent diuresis at home. The company became part of MannKind Corporation after MannKind completed its acquisition of scPharmaceuticals in October 2025.
At a glance
Attribute | Detail |
|---|---|
Founded | 2014 |
Headquarters | Burlington, Massachusetts |
Employees | 100-200 |
Revenue | 36.3M |
Ownership | Publicly traded (NASDAQ: SCPH) |
What scPharmaceuticals makes
The company's FUROSCIX On-Body Infusor is a wearable auto-injector that delivers its subcutaneous diuretic, and it is developing investigational products SCP-111 and scCeftriaxone for outpatient use.
Latest developments
2025-10-09 — MannKind completes acquisition of scPharmaceuticals in $296.5 million deal By Investing.com (investing.com)
2025-10-07 — MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care | MannKind Corporation (mannkindcorp.com)
2025-10-07 — MannKind completes acquisition of scPharmaceuticals; SCPH to be delisted from Nasdaq By Investing.com (investing.com)
2025-09-24 — scPharmaceuticals Inc. Form 8-K filed September 24, 2025 (sec.gov)
2025-08-26 — scPharmaceuticals Extends SmartDose Supply Agreement Until 2027 (ainvest.com)
2025-08-25 — Cooley, Latham Lead $360M ScPharmaceuticals Acquisition - Law360 UK (law360.com)
Company details
scPharmaceuticals was publicly listed under the ticker SCPH before its acquisition by MannKind Corporation, and it extended its SmartDose supply agreement through 2027 in August 2025. scPharmaceuticals was founded in 2014, has an estimated 100-200 employees, and is headquartered in Burlington, Massachusetts.
Frequently asked questions
What does scPharmaceuticals do?
scPharmaceuticals is a biopharmaceutical company headquartered in Burlington, Massachusetts, founded in 2014 and employing between 100 and 200 people. It develops subcutaneous delivery systems for cardiorenal care, serving patients with heart failure, chronic kidney disease, and fluid overload. Its lead product, FUROSCIX, is a subcutaneous diuretic delivered through a wearable on-body infusor that provides IV-equivalent diuresis at home. The company became part of MannKind Corporation after MannKind completed its acquisition of scPharmaceuticals in October 2025.
Where is scPharmaceuticals headquartered?
scPharmaceuticals is headquartered in Burlington, Massachusetts (25 Mall Rd, Burlington, Massachusetts, 01803-4108).
When was scPharmaceuticals founded?
scPharmaceuticals was founded in 2014.
How big is scPharmaceuticals?
scPharmaceuticals has an estimated 100-200 employees, with revenue in the 36.3M range.
Is scPharmaceuticals publicly traded?
Publicly traded (NASDAQ: SCPH). Public financial figures are drawn from its filings.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.